MedPath

A community-based trial to reduce malaria by improving homes and treating cattle in southwest Ethiopia.

Phase 3
Conditions
Malaria
Registration Number
PACTR202306667462566
Lead Sponsor
The Norwegian Programme for Capacity Development in Higher Education and Research for Development.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
9000
Inclusion Criteria

All households and members in the clusters assigned to either of the interventions or control and willing to sign informed consent to participate in the malaria study for two years will be included.
Villages close to the shores of the two Rift Valley lakes and endemic for malaria will be included in the study to minimize the variation between villages.
The flight distance of mosquitoes will be considered in selecting clusters for the study to reduce the diversion effect of the intervention and contamination due to mosquito movement.

All cattle except lactating cows and those planned to be used for meat in the near future will be involved in the study.

Exclusion Criteria

Those households that refuse to participate in the study or whose house structures are unsuitable for screening will be excluded.
Children below one year will not been enrolled in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Malaria incidence in all age groups above 1 year <br><br>Prevalence of malaria in all age groups above 1 year <br>
Secondary Outcome Measures
NameTimeMethod
•indoor and outdoor density of malaria mosquitoes <br>•prevalence of antibody against salivary gland antigens <br>•seroprevalence of malaria parasites<br>•cost-effectiveness of the intervention <br>•household multidimensional poverty reduction <br>•prevalence of gametocyte carriage in human hosts <br>•parasite density of symptomatic and asymptomatic malaria cases <br>•prevalence of anemia in children age between1-5 years <br>•spatio-temporal clustering of malaria in control and intervention arms <br>•sporozoite infection rate <br>•entomological inoculation rate <br>•blood meal index <br>•mosquito biting rates <br>•proportion of freshly fed mosquitoes with gametocyte <br>•malaria sero-conversion rate among children <br>•effectiveness of serological biomarkers in monitoring vector control<br>•community acceptance of the intervention <br>•durability of house screening <br>•ITNs use rate <br>•human night activities and sleeping patterns (time)<br>
© Copyright 2025. All Rights Reserved by MedPath